The official blog of the Lung Institute.

Lung Institute is Coming to Pittsburgh

23 Jun 2015
| Under Press | Posted by
The Lung Institute Pittsburgh

A Cellular Therapy Clinic is coming to Pittsburgh in July 2015

Pittsburgh, PA (June 23, 2015) – The Lung Institute is excited to be opening a fourth cellular therapy clinic in July of 2015. Many lung disease sufferers have opted in for cellular therapy to improve their quality of life. While cellular therapy isn’t a cure for lung disease, it has improved many patients’ quality of life. The Lung Institute uses cellular therapy to improve lung function. Everyone has cells in their body that act as our body’s system to promote healing. Cellular therapy specifically targets damaged areas and accelerates the healing process. The Lung Institute uses a minimally invasive procedure that extracts cells from fat tissue, blood or bone marrow, and reintroduces them back into the body, targeting the damaged lung tissue. Cellular therapy has significantly improved many patients’ lives by allowing them to breathe easier and do the things that they enjoy in life. We are looking forward to expanding to Pennsylvania, because the Lung Institute is coming to Pittsburgh next month.

Why Pittsburgh?

Pittsburgh is known as the “Steel City” because of the city’s historic past with the steel industry. While this has helped build a strong local economy, unfortunately it also comes with negative health repercussions. In fact, the occupational hazards of working in a steel mill can present just as much as a risk as smoking cigarettes, according to a report released by University of Sheffield’s Department of Medicine. Occupational Lung Disease in Pittsburgh is a real problem, and it’s time that sufferers have alternative options other than the traditional treatment methods.

Problems Facing Lung Disease Sufferers in Pittsburgh

The Workers’ Compensation Law was created to ensure that workers’ medical bills are taken care of by the employer when they develop a disease as a result of working on a job. However, the time limitations on the bill make many of those who suffer from occupational lung disease ineligible for coverage, mainly because the diseases take many years to develop and therefore workers don’t start to show symptoms right away. Treatment options for lung diseases are expensive – ranging from daily medications and supplemental oxygen to more extreme measures like lung reduction or transplant. Many lung disease sufferers, however, have found relief in minimally invasive cellular therapy. Breathe easy Pittsburgh, the Lung Institute is on its way.

About the Lung Institute

At the Lung Institute, we are changing people’s lives across the nation through the innovative technology of regenerative medicine. We recognize the challenges of finding effective and sustainable treatment options for patients who might be suffering from debilitating lung diseases, and we are committed to providing patients a more effective way to address pulmonary conditions and improve quality of life. Our goal is to help patients breathe easier and bring life back within reach. For more information, visit our website at LungInstitute.com, like us on Facebook, follow us on Twitter or call us today at 888-745-6697.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.